2,141 research outputs found

    Zein as a renewable material for the preparation of green nanoparticles for drug delivery

    No full text
    Environmental sustainability is a key challenge driven by the increased consumption of natural resources with limited availability. In this scenario agriculture has emerged as a privileged source of renewable resources, hence more efforts should be addressed to the study of plant-derived materials for medical applications. Zein is a biocompatible, biodegradable and amphiphilic prolamin protein extracted from the endosperm tissue of corn. For these reasons, its applications span from coatings for edible capsules, to the fabrication of bi- and tridimensional scaffolds for tissue engineering, and to develop drug delivery systems. This review aims at describing the properties and main applications of zein with a focus on the most recent and updated state of the art literature on zein based nanoparticles for the controlled delivery of various drugs. The main focus is to analyze the state of the art literature to understand how to implement sustainable methods for the preparation of zein NPs and to propose their exploitation as novel drug delivery systems for multiple applications, including oligonucleotide delivery. Main methods for zein NP preparation are described under an ecofriendly point of view, highlighting their environmental sustainability based on used solvents, waste products and energy consumption

    Green technologies and materials for the development of eco/biocompatible systems for drug delivery

    No full text
    L'abstract è presente nell'allegato / the abstract is in the attachmen

    3D bioartificial stretchable scaffolds mimicking the mechanical hallmarks of human cardiac fibrotic tissue

    No full text
    Human cardiac fibrotic tissues are characterized by a higher stiffness relative to healthy cardiac tissues. These tissues are unable to spontaneously contract and are subjected to passive mechanical stimulation during heart functionality. Moreover, scaffolds that can recapitulate the in vivo mechanical properties of the cardiac fibrotic tissues are lacking. Herein, this study aimed to design and fabricate mechanically stretchable bioartificial scaffolds with biomimetic composition and stiffness comparable to human cardiac fibrotic tissues. Poly(ε-caprolactone) (PCL) scaffolds with a stretchable mesh architecture were initially designed through structural and finite element method (FEM) analyses and subsequently fabricated by melt extrusion additive manufacturing (MEX). Scaffolds were surface functionalized by 3,4-dihydroxy-DL-phenylalanine (DOPA) polymerization (polyDOPA) to improve their interaction with natural polymers. Scaffold pores were then filled with different concentrations (5%, 7%, and 10% w/v) of gelatin methacryloyl (GelMA) hydrogels to support in vitro human cardiac fibroblasts (HCFs) 3D culture, thereby producing bioartificial PCL/GelMA scaffolds. Uniaxial tensile mechanical tests in static and dynamic conditions (1 Hz; 22% maximum strain) demonstrated that the bioartificial scaffolds had in vivo-like stretchability and similar stiffness to that of pathological cardiac tissue (tailored as a function of the number of PCL scaffold layers and GelMA hydrogel concentration). In vitro cell tests on bioartificial scaffolds using HCF-embedded GelMA hydrogels under static conditions displayed increasing cell viability, spreading, and cytoskeleton organization with decreasing GelMA hydrogel concentration. Moreover, α-smooth muscle actin (α-SMA)-positive cells were detected after 7 days of culture in static conditions followed by another 7 days of culture in dynamic conditions and not in HCF-loaded scaffolds cultured in static conditions for 14 days. These results suggested that in vitro culture under cyclic mechanical stimulations could induce an HCF phenotypic switch into myofibroblasts
    corecore